Inventor

BREINLINGER ERIC C

US11 patents

⚠️ This page may combine multiple inventors who share the name “BREINLINGER ERIC C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBVIE INC

5 patents

US9856253B2Jan 2, 2018

Tricyclic modulators of TNF signaling

ABBVIE INC2 citations68

US10508113B2Dec 17, 2019

Inhibitors of tyrosine kinase 2 mediated signaling

ABBVIE INC3 citations66

US10273238B2Apr 30, 2019

Indazolones as modulators of TNF signaling

ABBVIE INC0 citations48

US10106501B2Oct 23, 2018

Nuclear receptor modulators

ABBVIE INC1 citations48

US10266532B2Apr 23, 2019

Tricyclic modulators of TNF signaling

ABBVIE INC0 citations47

ABBOTT LAB

2 patents

US7834039B2Nov 16, 2010

Oxadiazole compounds

ABBOTT LAB36 citations88

US7709468B2May 4, 2010

Imidazo based heterocycles

ABBOTT LAB15 citations82

WISHART NEIL

1 patent

US8785639B2Jul 22, 2014

Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof

WISHART NEIL57 citations92

WALLACE GRIER A

1 patent

US8217027B2Jul 10, 2012

Sphingosine-1-phosphate receptor agonist and antagonist compounds

WALLACE GRIER A2 citations52

GEORGE DAWN M

1 patent

US9115151B2Aug 25, 2015

Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof

GEORGE DAWN M0 citations36

CALDERWOOD DAVID J

1 patent

US9029409B2May 12, 2015

Isoxazolines as therapeutic agents

CALDERWOOD DAVID J0 citations28